TULIPS – 1st to DEVELOP COVID SWABS IN INDIA. ALL SET TO INCREASE PRODUCTION TO 5 MILLION SWABS A WEEK TO BOOST COVID-19 DIAGNOSIS, Affordable innovation to cost one tenth of the imported swabs.ICMR Approved Certificate
Amid calls for increased coronavirus testing nationwide, Suparshva Swabs, India’s leading personal hygiene consumer product innovator and owner of the fast-growing popular brand TULIPS, is currently producing over 2 million COVID-19 SWABS per week, which would increase to over 5 million per week by the end of May, 2020, to accelerate COVID-19 testing.
To meet the national need for COVID-19 tests, the company is ramping up production, by converting its production lines and reconfiguring equipment, of some of its manufacturing capabilities. The company has the largest installed capacity of Cotton buds in Asia & possesses capability of taking the COVID-19 swab production to over 30 million swabs per week, if required in due course.
|Total length||Stick Dia||Swab Dia||Break Point||Indicator Mark|
|153 mm||2.25 mm||4.2 mm||64 mm||70 mm|
"Today's health crisis is unprecedented, so we all have to help wherever we can. While we are firm on meeting the national needs, we will also scale up and help others across the world.
We are convinced that widespread testing of those currently infected with COVID-19 will bring us out of the current lockdown as we do our bit to help the country return to normalcy.
We developed Polyester Spun Swabs for COVID-19 testing by converting our 100% Cotton processing lines, to produce these swabs, within 10 days flat. What is unique here, is that THE ENTIRE DEVELOPMENT WAS DONE IN-HOUSE & the trials were done on main production lines, which made us start producing the same day we received the ICMR approval,”
Rahul Jain, Partner, Suparshava Swabs.